The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1478-6354
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial ; volume:12 ; number:2 ; day:6 ; month:4 ; year:2010 ; pages:1-12 ; date:4.2010
Arthritis Research & Therapy ; 12, Heft 2 (6.4.2010), 1-12, 4.2010
- Urheber
-
Becker, Michael A.
- Beteiligte Personen und Organisationen
-
Schumacher, H Ralph
Espinoza, Luis R.
Wells, Alvin F.
MacDonald, Patricia
Lloyd, Eric
Lademacher, Christopher
SpringerLink (Online service)
- DOI
-
10.1186/ar2978
- URN
-
urn:nbn:de:1111-2016050314977
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:49 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Becker, Michael A.
- Schumacher, H Ralph
- Espinoza, Luis R.
- Wells, Alvin F.
- MacDonald, Patricia
- Lloyd, Eric
- Lademacher, Christopher
- SpringerLink (Online service)
Ähnliche Objekte (12)
Alterations in lipidome profiles distinguish early-onset hyperuricemia, gout, and the effect of urate-lowering treatment
Pleiotropic effect of the ABCG2 gene in gout: involvement in serum urate levels and progression from hyperuricemia to gout
A retrospective analysis of medication prescription records for determining the levels of compliance and persistence to urate-lowering therapy for the treatment of gout and hyperuricemia in The Netherlands
Urate-Lowering Agents in Asymptomatic Hyperuricemia: Role of Urine Sediment Analysis and Musculoskeletal Ultrasound
Variation in serum urate levels in the absence of gout and urate lowering therapy
The diffusion path reversibility confirms symmetry of surface barriers
Association between being African-American, serum urate levels and the risk of developing hyperuricemia: findings from the Coronary Artery Risk Development in Young Adults cohort
The effect for hyperuricemia inpatient of uric acid overproduction type or in combination with topiroxostat on the pharmacokinetics, pharmacodynamics and safety of dotinurad, a selective urate reabsorption inhibitor
The presence of monosodium urate deposits in the joints of patients with asymptomatic hyperuricemia is associated with a higher cardiovascular risk, but not with more advanced kidney damage
Urate-lowering therapy for gout and asymptomatic hyperuricemia in the pediatric population: a cross-sectional study of a Japanese health insurance database
Lithic usewear confirms the function of Wilamaya Patjxa projectile points
The prevalence of hyperuricemia in China: a meta-analysis
Alterations in lipidome profiles distinguish early-onset hyperuricemia, gout, and the effect of urate-lowering treatment
Pleiotropic effect of the ABCG2 gene in gout: involvement in serum urate levels and progression from hyperuricemia to gout
A retrospective analysis of medication prescription records for determining the levels of compliance and persistence to urate-lowering therapy for the treatment of gout and hyperuricemia in The Netherlands
Urate-Lowering Agents in Asymptomatic Hyperuricemia: Role of Urine Sediment Analysis and Musculoskeletal Ultrasound
Variation in serum urate levels in the absence of gout and urate lowering therapy
The diffusion path reversibility confirms symmetry of surface barriers
Association between being African-American, serum urate levels and the risk of developing hyperuricemia: findings from the Coronary Artery Risk Development in Young Adults cohort
The effect for hyperuricemia inpatient of uric acid overproduction type or in combination with topiroxostat on the pharmacokinetics, pharmacodynamics and safety of dotinurad, a selective urate reabsorption inhibitor
The presence of monosodium urate deposits in the joints of patients with asymptomatic hyperuricemia is associated with a higher cardiovascular risk, but not with more advanced kidney damage
Urate-lowering therapy for gout and asymptomatic hyperuricemia in the pediatric population: a cross-sectional study of a Japanese health insurance database
Lithic usewear confirms the function of Wilamaya Patjxa projectile points
The prevalence of hyperuricemia in China: a meta-analysis
Alterations in lipidome profiles distinguish early-onset hyperuricemia, gout, and the effect of urate-lowering treatment
Pleiotropic effect of the ABCG2 gene in gout: involvement in serum urate levels and progression from hyperuricemia to gout
A retrospective analysis of medication prescription records for determining the levels of compliance and persistence to urate-lowering therapy for the treatment of gout and hyperuricemia in The Netherlands
Urate-Lowering Agents in Asymptomatic Hyperuricemia: Role of Urine Sediment Analysis and Musculoskeletal Ultrasound
Variation in serum urate levels in the absence of gout and urate lowering therapy
The diffusion path reversibility confirms symmetry of surface barriers
Association between being African-American, serum urate levels and the risk of developing hyperuricemia: findings from the Coronary Artery Risk Development in Young Adults cohort
The effect for hyperuricemia inpatient of uric acid overproduction type or in combination with topiroxostat on the pharmacokinetics, pharmacodynamics and safety of dotinurad, a selective urate reabsorption inhibitor
The presence of monosodium urate deposits in the joints of patients with asymptomatic hyperuricemia is associated with a higher cardiovascular risk, but not with more advanced kidney damage
Urate-lowering therapy for gout and asymptomatic hyperuricemia in the pediatric population: a cross-sectional study of a Japanese health insurance database
Lithic usewear confirms the function of Wilamaya Patjxa projectile points